Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-02-22 00:11 | 2018-02-16 | CVS | CVS HEALTH Corp | Foulkes Helena | Officer; EVP & President-CVS Pharmacy | Retail-Drug Stores and Proprietary Stores | OPT+S | $71.04 | 19,965 | $1,418,314 | 45,107 | -30.7% |
| 2017-09-19 23:44 | 2017-09-15 | CVS | CVS HEALTH Corp | Foulkes Helena | Officer; EVP & President-CVS Pharmacy | Retail-Drug Stores and Proprietary Stores | OPT+S | $81.88 | 39,340 | $3,221,159 | 44,997 | -46.6% |
| 2017-06-28 23:51 | 2017-06-26 | CVS | CVS HEALTH Corp | Foulkes Helena | Officer; EVP, President-CVS Pharmacy | Retail-Drug Stores and Proprietary Stores | OPT+S | $80.00 | 20,333 | $1,626,640 | 44,997 | -31.1% |
| 2017-06-21 23:56 | 2017-06-19 | CVS | CVS HEALTH Corp | Foulkes Helena | Officer; EVP, President-CVS Pharmacy | Retail-Drug Stores and Proprietary Stores | OPT+S | $76.98 | 20,332 | $1,565,157 | 44,997 | -31.1% |
| 2014-11-11 01:11 | 2014-11-07 | CVS | CVS HEALTH Corp | Foulkes Helena | Officer; EVP, President-CVS/pharmacy | Retail-Drug Stores and Proprietary Stores | OPT+S | $88.06 | 46,325 | $4,079,583 | 18,076 | -71.9% |
| 2013-11-26 01:44 | 2013-11-21 | HD | HOME DEPOT, INC. | Foulkes Helena | Director | Retail-Lumber & Other Building Materials Dealers | BUY | $79.73 | 313 | $24,955 | 313 | +100.0% |
| 2013-11-16 00:03 | 2013-11-14 | CVS | CVS HEALTH Corp | Foulkes Helena | Officer; Executive Vice President | Retail-Drug Stores and Proprietary Stores | OPT+S | $65.00 | 24,114 | $1,567,410 | 17,911 | -57.4% |
| 2013-09-13 23:05 | 2013-09-12 | CVS | CVS HEALTH Corp | Foulkes Helena | Officer; Executive Vice President | Retail-Drug Stores and Proprietary Stores | OPT+S | $60.00 | 53,546 | $3,212,760 | 17,817 | -75.0% |
| 2013-09-11 23:19 | 2013-09-09 | CVS | CVS HEALTH Corp | Foulkes Helena | Officer; Executive Vice President | Retail-Drug Stores and Proprietary Stores | OPT+S | $58.65 | 47,568 | $2,789,863 | 17,817 | -72.8% |
| 2012-06-22 23:03 | 2012-06-21 | CVS | CVS HEALTH Corp | Foulkes Helena | Officer; Executive Vice President | Retail-Drug Stores and Proprietary Stores | OPT+S | $45.97 | 93,424 | $4,295,084 | 8,763 | -91.4% |
| 2012-03-03 00:06 | 2012-03-01 | CVS | CVS HEALTH Corp | Foulkes Helena | Officer; Executive Vice President | Retail-Drug Stores and Proprietary Stores | OPT+S | $44.87 | 25,874 | $1,160,876 | 11,172 | -69.8% |
| 2011-06-20 22:58 | 2011-06-16 | CVS | CVS HEALTH Corp | Foulkes Helena | Officer; Executive Vice President | Retail-Drug Stores and Proprietary Stores | OPT+S | $37.49 | 26,953 | $1,010,468 | 12,753 | -67.9% |
| 2010-03-18 23:01 | 2010-03-17 | CVS | CVS HEALTH Corp | Foulkes Helena | Officer; Senior Vice President | Retail-Drug Stores and Proprietary Stores | SALE | $34.93 | 7,000 | $244,510 | 863 | -89.0% |
| 2010-02-19 23:43 | 2010-02-18 | CVS | CVS HEALTH Corp | Foulkes Helena | Officer; Senior Vice President | Retail-Drug Stores and Proprietary Stores | SALE | $34.00 | 12,280 | $417,520 | 8,406 | -59.4% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.